JP6932154B2 - Drug management system and drug management method - Google Patents

Description

The present invention relates to a drug management system and a drug management method.

In recent years, the handling volume of medicines called specialty medicines such as anticancer drugs, hemophilia treatments, biopharmaceuticals, plasma fractionation products, vaccine products, companion diagnostics, rare disease products, regenerative medicine products, etc. has increased. It has increased. Pharmaceuticals in these specialty areas are often required to have a high degree of traceability and environmental environment control including strict temperature control such as 2 to 8 ° C., 15 to 25 ° C., and 0 ° C. or lower.

On the other hand, these drugs tend to have characteristics such as difficulty in forecasting demand and short expiration dates, so medical institutions and insurance pharmacies (hereinafter, these are collectively referred to as medical institutions, etc.). Often, these medicines are not consumed as planned at (including retailers). In addition, the unit price of these drugs is high, and there is a risk that the drug prices of drugs owned by medical institutions and the like may be impaired due to regular drug price revisions. In recent years, the period for drug price revisions has tended to be shortened from the perspective of optimizing social security costs, and drug prices will be revised in a shorter period of time for high-priced drugs whose demand has expanded more than expected. There is an increasing risk that drug prices will be impaired. In addition, in the revision of drug prices, adjustments including negotiation of transaction conditions and various processes associated with the negotiation between drug manufacturers and distributors (including wholesale companies and logistics companies, manufacturers and insurance pharmacies), medical institutions, etc. There will be costs.

In addition, as medical expenses are being optimized, the business environment surrounding medical institutions is becoming harsher, and it is desirable to improve the cash flow of medical institutions in order to continue regional medical care. With the desire to improve cash flow while the risk of drug price impairment increases, holding a large number of drugs in stock by medical institutions can be a risk of deteriorating cash flow of medical institutions. Even if a manufacturer launches a new specialty drug, if medical institutions concerned about the deterioration of cash flow reduce the inventory of many drugs, it will be difficult to administer the drug to patients at the right time. , So-called reduced patient access. The business environment of distributors is becoming harsher, as is the case with medical institutions. In addition, due to the social issue of a decrease in the working population, adjustment costs associated with drug price revisions and medical institutions are suddenly reducing their inventories. There are issues such as increased distribution costs such as delivery and returns, and increased risk of inventory damage.

On the other hand, regarding the management of medicines, pharmacists belonging to medical institutions that own medicines manage them locally in order to deal with loss, theft, security management, inventory of medicines, quality, expiration date, and maintenance of storage environment. Is stipulated by law. However, managing medicines in this way can be a labor burden for pharmacists and can be a factor that hinders work style reforms. In addition, despite the implementation of such management, the current situation is that theft or loss of medicines, shortages, expiration dates, quality deviations, etc. may occur.

Japanese Patent No. 6235650

On the one hand, the disclosed technology is to solve the above-mentioned problems, and the purpose is to ensure the administration of the drug to the patient at an appropriate timing, while the medical institution or the like holds the drug in stock. It is to provide a drug management system and a drug management method that can reduce the risk caused by the above.

One aspect of the disclosed technology is exemplified by the following drug management system. This drug management system includes a storage means for storing drugs delivered from a drug distributor to a medical institution, a management means for managing the drug and the owner of the drug in association with each other, and a drug stored in the storage means. The management means is provided with a detection means for detecting that the medical institution has taken out the drug, and when the detection means detects that the medical institution has taken out the drug from the storage means, the brought-out drug is used. It is characterized in that the associated owner is changed to the medical institution.

In the disclosed technology, the detection means detects the take-out of the drug stored in the storage means, and then the owner of the drug is changed to a medical institution. That is, the owner of the drug is not a medical institution when it is stored in the storage means. In other words, the medicines stored in the storage means are not in stock at the medical institution until they are taken out from the storage means, and are not subject to the claim from the distributor to the medical institution. Further, since the medicine delivered to the medical institution is stored in the storage means, the medical institution can easily take out the medicine from the storage means at the timing of administration to the patient. Therefore, according to the disclosed technology, it is possible to reduce the risk of a medical institution or the like holding a drug as an inventory while ensuring the administration of the drug to a patient at an appropriate timing.

The disclosed technique may have the following features: When a predetermined period of time indicating the use of the drug has elapsed after the detection means detects that the drug has been taken out from the storage means, the management means provides the owner associated with the brought-out drug to the medical treatment. It is characterized by changing to an institution. By having such a feature, it is possible to prevent the drug from being billed as soon as the drug different from the drug intended by the medical institution is taken out from the storage means.

The disclosed technique may have the following features: When the drug whose owner has been changed to the medical institution is returned to the storage means, the management means determines whether or not the drug returned to the storage means satisfies a predetermined condition, and in the case of an affirmative determination. The owner associated with the medicinal product returned to the storage means is changed to the distributor. The predetermined condition is, for example, a condition indicating that the quality of the pharmaceutical product taken out from the storage means does not deteriorate. If the target drug is a drug in the specialty area, the predetermined condition is the time when the drug is exposed to an environment other than the environmental conditions required for storage of the drug (for example, the time when the drug is taken out from the storage means). The quality of the drug is within the sustainable time, the remaining expiration date is not different from the inventory held by the distributor, there is no damage, stain, opening, discontinuation of sales, change of packaging, sale Including that there is no transfer of manufacturers. In addition, the predetermined condition may include that the target drug is an ordinary drug that does not belong to the specialty area, and that the drug is unused. By having such a feature, it is possible to prevent the medical institution from holding unused medicines in inventory and to make a claim to the medical institution.

The disclosed technique may have the following features: The drug is given an identifier that uniquely identifies the drug, the storage means is provided with a reading means for reading the identifier, and the management means includes the identifier of the drug and the distributor that delivers the drug. The detection means is managed in association with each other, and the detection means identifies a distributor who has delivered each of the medicines stored in the storage means based on the identifier read by the reading means and the management means. .. By having such a feature, even when medicines delivered from multiple distributors are stored in one storage means, it is possible to identify from which distributor each stored medicine is delivered. be able to. That is, it is possible to store medicines from a plurality of distributors in one storage means.

The disclosed technique may have the following features: The storage means is characterized in that the delivered drug is stored while maintaining the environmental conditions corresponding to the delivered drug. By having such characteristics, the disclosed technology can be applied to pharmaceutical products in the specialty area where environmental environment control including strict temperature control is required.

The disclosed technique may have the following features: The management means further includes a generation unit in which the owner generates billing data for the drug associated with the medical institution with the owner as the billing destination. Having such a feature allows the owner to generate billing data for the drug that has been changed to a medical institution.

The disclosed technology can also be grasped from the aspect of the method.

The technology of the present disclosure can reduce the risk of holding a drug in inventory by a medical institution or the like while ensuring the administration of the drug to a patient at an appropriate timing.

FIG. 1 is a diagram showing an example of a mode of distribution of a drug according to an embodiment. FIG. 2 is a diagram showing an example of a distribution warehouse in the embodiment. FIG. 3 is a diagram showing an example of a processing block of the management server in the embodiment. FIG. 4 is a diagram showing an example of a distribution warehouse management table stored in the management database in the embodiment. FIG. 5 is a diagram showing an example of a business operator management table stored in the management database in the embodiment. FIG. 6 is a diagram showing an example of the processing flow of the management server according to the embodiment.

Hereinafter, embodiments will be described with reference to the drawings. The configurations of the embodiments shown below are examples, and the disclosed technology is not limited to the configurations of the embodiments.

<Embodiment>
FIG. 1 is a diagram showing an example of a drug management system according to an embodiment. FIG. 1 shows an example of a mode of distribution of a drug 5 using a drug management system. In the present embodiment, the identification element 5a on which the ID of the drug 5 is recorded is attached to the drug 5 (the drug itself or the packaging of the drug). Further, the drug 5 that delivers the reading sensors 6a and 16a capable of detecting the identification information of the drug 5 by the identification element 5a and the temperature sensors 6b and 16b capable of acquiring the internal temperature history information from the drug manufacturer 1 to the distributor 2. It is attached to the cold storage container 6 for storing and the cold storage container 16 for storing the drug 5 to be delivered from the distributor 2 to the medical institution or the like 3. Then, the output signals of the reading sensors 6a and 16a and the temperature sensors 6b and 16b are transmitted to the management server 8 by wireless communication and recorded as necessary. As a result, information on whether or not the drug 5 having a predetermined ID is stored in the cold storage containers 6 and 16 and temperature history information in the cold storage containers 6 and 16 can be recorded in real time. As a result, it becomes possible to detect that the drug 5 is reliably stored in the cold storage containers 6 and 16 while the drug is being transferred from the drug manufacturer 1 to the distributor 2 and from the distributor 2 to the medical institution 3 and the like. The temperature history in the cold storage containers 6 and 16 can be recorded. The cold storage containers 6 and 16 may be used as packaging for the pharmaceutical product 5.

Further, in the present embodiment, the reading sensors 7a and 17a and the temperature history capable of detecting the identification information of the drug 5 by the identification element 5a also in the refrigerated storage 7 provided by the distributor 2 and the distribution warehouse 17 provided by the medical institution 3 and the like 3 are provided. Temperature sensors 7b and 17b capable of acquiring information are attached. Then, the output signals of the reading sensors 7a and 17a and the temperature sensors 7b and 17b are transmitted and recorded in real time to the management server 8 by wireless communication. As a result, information on whether or not the drug 5 having a predetermined ID is stored in the refrigerated storage 7 or the branch warehouse 17 and whether or not the drug 5 stored in the branch warehouse 17 is taken out. This information and the temperature history information in the refrigerated storage 7 and the branch warehouse 17 can be recorded in real time. The reading sensor 17a is an example of a “reading means”.

Here, the identification element 5a may be, for example, an IC tag or an RFID tag (including both an active type and a passive type and may be a temperature sensor integrated type), and in this case, the reading sensors 6a and 16a. , 7a, 17a may be RFID readers. Further, the identification element 5a and the reading sensors 6a, 16a, 7a, 17a may be configured by a device capable of short-distance wireless communication such as Bluetooth (registered trademark). Further, the identification element 5a may be a device that emits a magnetic field or light that can identify the ID of the drug 5, and in this case, the reading sensors 6a, 16a, 7a, 17a are magnetic sensors or optical sensors. May be good. Further, the identification element 5a does not have to actively transmit a signal such as an electromagnetic field or light, and may be, for example, a label on which a barcode or a QR code (registered trademark) is printed. In this case, the reading sensors 6a, 16a, 7a, 17a may be a barcode reader or a QR code (registered trademark) reader. The identification element 5a is an example of an "identifier".

Further, as described above, the reading sensors 6a, 16a, 7a, 17a and the temperature sensors 6b, 16b, 7b, 17b are provided with a communication function, and the information management device 8 is provided with information on the ID and location of the drug 5 and temperature history information. And may be received and recorded in the information management device 8 in real time, but the reading sensors 6a, 16a, 7a, 17a and the temperature sensors 6b, 16b, 7b, 17b themselves, the cold storage containers 6, 16 Alternatively, the cold storages 7 and 17 may be provided with a storage function to independently record and store each information.

The distribution warehouse 17 is, for example, a refrigerated storage (including a refrigerator, a freezer, a shelf, a cold storage container, and a cold storage room) provided in three facilities such as a medical institution. The distribution warehouse 17 stores the drug 5 delivered from the distributor 2 while maintaining a temperature environment suitable for the drug 5. FIG. 2 is a diagram showing an example of a distribution warehouse in the embodiment. FIG. 2 illustrates a state in which the branch warehouse 17 is viewed from the front, and the door of the branch warehouse 17 is not shown for the sake of explanation. Inside the distribution warehouse 17, a plurality of shelves 17c on which the reading sensor 17a, the temperature sensor 17b, and the drug 5 are placed are provided. In the figure, the reading sensor 17a is provided inside the left and right side walls of the divided warehouse 17, and the temperature sensor 17b is provided inside the divided warehouse 17 near the ceiling, but the reading sensor 17a and the temperature are provided. The position of the sensor 17b is not limited to this. The reading sensor 17a may be provided at a position suitable for detecting the identification information of the drug 5 by the identification element 5a attached to the drug 5 stored in the distribution warehouse 17, and may be a non-attachable type such as a handy scanner or a smartphone. No. Further, the temperature sensor 17b may be provided at a position different from the vicinity of the ceiling as long as it is a position suitable for measuring the temperature in the distribution warehouse 17, or may be thermography. The distribution warehouse 17 is an example of “storage means”.

The management server 8 is an information processing device including a Central Processing Unit (CPU) 81, a main storage unit 82, an auxiliary storage unit 83, and a communication unit 84. The main storage unit 82 and the auxiliary storage unit 83 are recording media that can be read and written by the management server 8. The main storage unit 82 is exemplified as a storage unit that is directly accessed from the CPU 81. The main memory 82 is a Random Access Memory (RAM) and a Read Only Memory.
Includes ory (ROM). The auxiliary storage unit 83 stores various programs and various data in a readable and writable recording medium. The auxiliary storage unit 83 is also called an external storage device.

The auxiliary storage unit 83 stores an operating system (Operating System, OS), various programs, various tables, and the like. The auxiliary storage unit 83 is, for example, an Erasable Programmable ROM (EPROM), a solid state drive (Solid State Drive, SSD), a hard disk drive (Hard Disk Drive, HDD), or the like. The communication unit 84 is a wireless or wired communication interface with another device. In the management server 8, the CPU 81 expands the program stored in the auxiliary storage unit 83 into the work area of the main storage unit 82, and controls peripheral devices through the execution of the program. As a result, the management server 8 can execute the process that meets the predetermined purpose.

The place where the management server 8 is installed is not particularly limited. For example, the management server 8 may be installed in the facility of the distributor 2, may be installed in the facility of the management company of the cold storage containers 6 and 16, or may be installed in the management company of the refrigerating storage 7. Alternatively, it may be installed in a medical institution or the like 3 having a distribution warehouse 17. Further, the management server 8 may be installed on the cloud. Further, the management server 8 may be composed of a plurality of servers instead of one server.

<Processing block of management server 8>
FIG. 3 is a diagram showing an example of a processing block of the management server in the embodiment. The management server 8 includes a detection unit 801, a return processing unit 802, a billing data creation unit 803, and a management database 804. In the figure, the database is referred to as DB and the table is referred to as TBL. In the management server 8, the CPU 81 executes a computer program executably deployed in the main storage unit 82, so that the management server 8 has a detection unit 801 and a return processing unit 802, a billing data creation unit 803, and a management database 804. Etc. are executed as each part.

The management database 804 contains information on processing from the ordering of the drug 5 from the medical institution 3 by the distributor 2 to the delivery of the drug 5 to the medical institution 3, information on the inventory of the medical institution 3, and information on billing. It is a database to manage. The management database 804 includes a distribution warehouse management table 804a, a business operator management table 804b, a distribution status management table 804c, and a cold storage container management table 804d.

The distribution warehouse management table 804a is a table for managing information from the distribution warehouse 17. The detection unit 801 receives the output signals from the reading sensor 17a and the temperature sensor 17b in real time, and stores the received information in the distribution warehouse management table 804a.

FIG. 4 is a diagram showing an example of a distribution warehouse management table stored in the management database in the embodiment. The distribution warehouse management table 804a exemplified in FIG. 4 stores, for example, information related to the drug 5 generated for each distribution warehouse 17 and stored in the distribution warehouse 17. The distribution warehouse management table 804a includes each item of "pharmaceutical product ID", "distributor ID", "owner ID", and "drug price". An ID that uniquely identifies the drug 5 is stored in the “drug ID”. The ID that uniquely identifies the drug 5 is, for example, the identification information of the drug 5 by the identification element 5a. In the "distributor ID", a distributor ID that uniquely identifies the distributor 2 that delivers the drug 5 to the medical institution or the like 3 is stored. In the "owner ID", a trader ID indicating a trader owned by the drug 5 is stored. The price (drug price) of the drug 5 is stored in the "drug price". As the price of the drug 5, the selling price from the distributor 2 to the medical institution or the like 3 may be applied.

FIG. 5 is a diagram showing an example of a business operator management table stored in the management database in the embodiment. The business operator management table 804b exemplified in FIG. 5 includes each item of "trader ID", "type", "name", and "warehouse ID". The "trader ID" stores an ID that uniquely identifies the distributor 2, the medical institution, and the like 3. In the "type", information indicating the distinction between the distributor, the medical institution, and the like is stored. In the "name", the name of the distributor 2 or the medical institution 3 corresponding to the "trader ID" is stored. In the "warehouse ID", an ID for identifying the refrigerated storage 7 or the branch warehouse 17 owned by the distributor 2 or the medical institution 3 corresponding to the "warehouse ID" is stored.

The distribution status management table 804c contains information on the ID of the drug 5 from the cold storage containers 6, 16, the refrigerated storage 7, and the branch warehouse 17, the location or existence (including those by warehousing and withdrawal), and temperature history information. And, the information related to the processing of the withdrawal / return of the drug 5 in the present embodiment is stored. The management server 8 may provide, for example, the information stored in the distribution state management table 804b to the pharmaceutical manufacturer 1. For example, the management server 8 may provide the drug manufacturer 1 with information on the ID, location or existence (including those by warehousing and withdrawal) of the drug 5, and temperature history information.

The cold storage container management table 804d is a table that manages information from the cold storage containers 6 and 16. The management server 8 receives the output signals from the reading sensors 6a and 16a and the temperature sensors 6b and 16b in real time, and stores the received information in the cold storage container table 804d. The refrigerated storage management table 804e is a table for managing information from the refrigerated storage 7. The detection unit 801 receives the output signals from the reading sensor 7a and the temperature sensor 7b in real time, and stores the received information in the refrigerating storage management table 804e. The management database 804 is an example of "management means".

The detection unit 801 detects that the drug 5 has been taken out from the distribution warehouse 17 based on the output signal from the reading sensor 17a. If the drug 5 taken out within the use determination period indicating the use of the drug 5 is not returned to the distribution warehouse 17, the detection unit 801 is the owner associated with the drug 5 taken out in the distribution warehouse management table 804a. Is updated to 3 such as medical institutions. That is, at the stage when the drug 5 is stored in the distribution warehouse 17, the detection unit 801 keeps the owner of the drug 5 as the distributor 2 and does not change to the medical institution or the like 3. The detection unit 801 is an example of "detection means". The use determination period is an example of "a predetermined period indicating the use of a drug".

The return processing unit 802 detects that the drug 5 taken out from the distribution warehouse 17 has been returned to the distribution warehouse 17 based on the output signal from the reading sensor 17a. When the returned drug 5 satisfies a predetermined returnable condition, the return processing unit 802 returns the owner associated with the drug 5 in the distribution warehouse management table 804a to the distributor 2.

The billing data creation unit 803 creates billing data for the drug 5 whose owner has been changed to a medical institution or the like 3 in the branch warehouse management table 804a. The billing data creation unit 803 acquires an owner for each of the medicines 5 stored in the distribution warehouse management table 804a, for example. The billing data creation unit 803 refers to the business operator management table 804b and determines whether or not the acquired owner is a medical institution or the like 3. When the owner is a medical institution or the like 3, the billing data creation unit 803 determines that the drug 5 is the target of the billing data creation, and creates the billing data for the drug 5. The billing data creation unit 803 is an example of a “generation unit”.

(Processing flow)
FIG. 6 is a diagram showing an example of the processing flow of the management server according to the embodiment. Hereinafter, an example of the processing flow of the management server 8 according to the embodiment will be described with reference to FIG.

In S1, the detection unit 801 determines whether or not the drug 5 has been taken out from the distribution warehouse 17 based on the output signal from the reading sensor 17a. In the case of affirmative determination (YES in S1), the process proceeds to S2. In the case of a negative determination (NO in S1), the process of S1 is repeated.

In S2, the detection unit 801 determines whether or not the drug 5 detected in S1 has been returned to the distribution warehouse 17 within the usage determination period indicating the use of the drug 5 based on the output signal from the reading sensor 17a. To judge. In the case of an affirmative determination (YES in S2), the process is returned to S1. In the case of a negative determination (NO in S2), the process proceeds to S3.

In S3, the detection unit 801 updates the owner associated with the drug 5 taken out in S1 to the medical institution or the like 3 in the distribution warehouse management table 804a. In S4, the return processing unit 802 determines whether or not the drug 5 taken out in S1 has been returned to the distribution warehouse 17 after the usage determination period has elapsed, based on the output signal from the reading sensor 17a. In the case of an affirmative determination (YES in S4), the process proceeds to S5. In the case of a negative determination (NO in S4), the process proceeds to S7.

In S5, the return processing unit 802 determines whether or not the drug 5 returned to the distribution warehouse 17 in S4 satisfies the returnable condition. The returnable condition is, for example, when the drug 5 is a drug that does not require strict control of the surrounding environment (for example, a drug that does not belong to the specialty area), even if the returnable condition is satisfied when the drug 5 is unused. good. Whether or not it is unused is determined by, for example, when the identification element 5a is attached to each of the packaging of the drug 5 and the drug 5, the reading sensor 17a of the distribution warehouse 17 reads the identification element 5a attached to the drug 5. However, when the identification element 5a attached to the package cannot be read, it may be possible to determine that the drug 5 has been unpacked and used. Further, if the drug 5 is a drug in the specialty area, the time when the drug 5 is exposed to an environment other than the environmental conditions required for storage of the drug 5 (for example, the time when the drug 5 is taken out from the branch warehouse 17) is the time when the drug 5 is taken out. The returnability condition may be met if the quality is within a sustainable time. In the case of affirmative determination (YES in S5), the process proceeds to S6. In the case of a negative determination (NO in S5), the process proceeds to S7.

In S6, the return processing unit 802 updates the owner associated with the drug 5 returned to the distribution warehouse 17 in S4 to the medical institution or the like 3 in the distribution warehouse management table 804a. In S7, the billing data creation unit 803 refers to the distribution warehouse management table 804a and acquires the owner ID of the owner associated with each of the medicines 5. The billing data generation unit 803 identifies the drug 5 whose owner is a medical institution or the like 3 based on the acquired owner ID and the business management table 804b. The billing data generation unit 803 creates billing data for the drug 5 whose owner is the medical institution or the like 3 based on the drug price or the like associated with the drug 5 in the distribution warehouse management table 804a.

<Action and effect of the embodiment>
In the embodiment, the owner of the drug 5 delivered by the distributor 2 to the branch warehouse 17 of the medical institution or the like 3 remains the distributor 2 at the stage of delivery. In the embodiment, when the medicine 5 is taken out from the distribution warehouse 17 when the medical institution 3 uses the medicine 5, the owner of the taken medicine 5 is changed from the distributor 2 to the medical institution 3. That is, until the medical institution 3 actually uses the drug 5, the drug 5 stored in the branch warehouse 17 is not in stock of the medical institution 3, and the distributor 2 goes to the medical institution 3. Not subject to billing. Further, since the medical institution 3 can store the drug 5 in the branch warehouse 17, it is possible to administer the drug 5 to the patient at an appropriate timing. That is, according to the embodiment, it is possible to reduce the risk of the medical institution or the like 3 holding the drug 5 as an inventory while ensuring the administration of the drug 5 to the patient at an appropriate timing.

In the embodiment, the drug 5 is attached with the identification element 5a, and in the distribution warehouse management table 804a, the drug ID indicated by the identification element 5a and the distributor ID indicating the distributor 2 are associated with each other. Therefore, even if the medicines 5 delivered from the plurality of distributors 2 are mixed in the distribution warehouse 17, the distributors 2 who have delivered the medicines 5 can be specified. That is, even if the medicines 5 from the plurality of distributors 2 are mixed in the distribution warehouse 17, according to the present embodiment, the billing data is generated with the distributor 2 who delivered each medicine 5 as the billing source. can do.

In the embodiment, the identification elements 5a are read by the reading sensors 7a and 17a, and the management server 8 executes management based on the read signals. Therefore, according to the present embodiment, the drug 5 can be managed by remote management without the pharmacist managing the drug 5 in the branch warehouse 17. That is, it is possible to reduce the workload of pharmacists and improve the labor efficiency of medical sites.

<Modification example>
In the above embodiment, the example in which the environmental condition required for the management of the drug 5 is the ambient temperature of the drug 5 has been described, but the present invention describes the environmental condition required for the management of the drug 5. May be applied if is another condition. For example, the disclosed technology may be applied to the case where humidity, illuminance, shock, vibration, atmospheric pressure, or a combination of these conditions including temperature is used as the environmental conditions required for the management of the drug 5. ..

In the above embodiment, the management server 8 can manage whether the drug 5 having a predetermined ID is stored in the distribution warehouse 17. Therefore, the management server 8 can detect whether or not the quantity of the medicines 5 stored in any of the distribution warehouses 17 is equal to or more than a predetermined amount. When the management server 8 detects that the quantity of the medicines 5 stored in the distribution warehouse 17 of a certain medical institution 3 is equal to or more than a predetermined amount, the surplus medicines 5 are stored in the distribution warehouse of another medical institution 3 or the like. It may be delivered to 17 (for example, a distribution warehouse 17 in which the quantity of the stored medicine 5 is less than a predetermined amount). By adopting such a configuration, it is possible to adjust the excess or deficiency of the drug 5 among the medical institutions and the like 3.

In the above embodiment, one branch warehouse 17 is installed in the medical institution or the like 3, but a plurality of branch warehouses 17 may be installed in the medical institution or the like 3. The plurality of branch warehouses 17 may be installed in each of three departments such as medical institutions. The departments are, for example, a pharmacy department, an operating room, a chemotherapy room, an intensive care unit (ICU), a neonatal intensive care unit (NICU), a ward, a private room for inpatients (bedside of inpatients, etc.). In such a case, if there is a shortage of a certain drug 5 in the branch warehouse 17 set up in a certain department (for example, NICU) of a medical institution or the like 3, the drug 5 is taken from the branch warehouse 17 installed in another department. It may be delivered to the branch warehouse 17 installed in the NICU. By delivering the drug 5 within the above-mentioned usage determination period, the owner of the drug 5 can remain the distributor 2. That is, even if the drug 5 is delivered between the branch warehouses 17 in the medical institution 3, etc., the medical institution, etc. 3 does not have to hold the drug 5 as inventory of the medical institution, etc. 3.

Further, the processing in the above-described embodiment may be systematically automatically processed by the above-mentioned management server 8 based on a predetermined program as much as possible, but the disclosed technique is described above. The purpose is to include a technique as a method of manually executing the processing according to the embodiment by human resources.

In the above-described embodiment, a drug in a specialty area that requires strict temperature control including ambient environment control has been described as an example, but the drug targeted by the disclosed technology is not limited to the drug in the specialty area. .. The disclosed technology is also applicable to, for example, pharmaceuticals that can be stored at room temperature, non-medical pharmaceuticals, quasi-drugs, medical devices, and medical materials. When the disclosed technique is applied to a drug that can be stored at room temperature, for example, the distribution warehouse 17 may not be a refrigerated storage but a storage that does not have a temperature control function.

The embodiments and modifications disclosed above can be combined with each other.

1 ... Pharmaceutical manufacturer 2 ... Distributor 3 ... Medical institution 5 ... Pharmaceutical 5a ... Identification element 6, 16 ... Cold container 7 ... Refrigerated storage 17 ... Minutes Ground warehouse 7a, 17a ... Reading sensor 7b, 17b ... Temperature sensor 8 ... Management server 81 ... CPU
82 ... Main storage unit 83 ... Auxiliary storage unit 84 ... Communication unit 801 ... Detection unit 802 ... Return processing unit 803 ... Billing data creation unit 804 ... Management database 804a ...・ Branch warehouse management table 804b ・ ・ ・ Business management table 804c ・ ・ ・ Distribution status management table 804d ・ ・ ・ Cold storage container management table 804e ・ ・ ・ Cold storage management table

Claims (6)

A storage method for storing medicines delivered from drug distributors to medical institutions,
A storage unit that stores a management table that manages the drug and the owner of the drug in association with each other.
A detection means that detects that the medicines stored in the storage means have been taken out based on the output signal from the reading sensor, and
With a processor,
When a predetermined period indicating the use of the drug has elapsed after the detection means detects that the drug has been taken out from the storage means, the processor is associated with the owner associated with the brought-out drug in the management table. Is changed to the medical institution.
Drug management system. The processor
When the drug whose owner has been changed to the medical institution is returned to the storage means, it is determined whether or not the drug returned to the storage means satisfies a predetermined condition.
In the case of an affirmative determination, the owner associated with the drug returned to the storage means in the management table is changed to the distributor.
The drug management system according to claim 1. The drug is given an identifier that uniquely identifies the drug.
The storage means is provided with a reading means for reading the identifier.
The management table associates the identifier of the drug with the distributor that delivers the drug.
The processor is characterized in that it identifies a distributor who has delivered each of the medicines stored in the storage means based on the identifier read by the reading means and the management table.
The drug management system according to claim 1. The storage means is characterized in that the delivered drug is stored while maintaining the environmental conditions corresponding to the delivered drug.
The drug management system according to any one of claims 1 to 3. The processor further executes a process of generating billing data with the owner as a billing destination for a drug associated with the medical institution in the management table.
The drug management system according to any one of claims 1 to 4. Possession of medicines and medicines by connecting to a detection means that detects that the medicines stored in the storage means for storing medicines delivered from the medicine distributor to the medical institution are taken out based on the output signal from the reading sensor. A computer equipped with a storage unit that stores a management table that associates with a person
When a predetermined period indicating the use of the drug has elapsed after the detection means detects that the drug has been taken out from the storage means, the owner associated with the taken-out drug in the management table is assigned to the medical institution. Characterized by changing to,
Drug management method.

Images